Vaccines and the Microbiome

The bacteria that exist throughout the human body, known as the microbiome, play a variety of roles in the development of the immune system. This is particularly true during infancy when the microbiome and the immune response are developing in tandem. Most vaccines are administered in early childhood to prevent outbreaks of devastating childhood diseases. A higher relative abundance of the phylum Actinobacteria (oral and parenteral vaccines) and Firmicutes (oral vaccines) was associated with both higher humoral and higher cellular vaccine responses, while a higher relative abundance of the phylum Proteobacteria (oral and parenteral vaccines) and Bacteroidetes (oral vaccines) was associated with lower responses. Subjects whose intestinal microbiota is dominated by Bifidobacterium demonstrated a broader level of adaptive immune response to vaccinations. On the other hand, infants with higher ratios of Enterobacteriales, Pseudomonadales, and Clostridiales in their intestinal microbiota exhibited lower immune response to vaccination.

 

    Related Conference of Vaccines and the Microbiome

    June 24-25, 2019

    48th World Congress on Microbiology

    Moscow, Russia
    July 01-02, 2019

    11th International Virology Summit

    Valencia, spain
    July 26-27, 2019

    World Yeast Congress

    Vancouver | Canada
    October 21-22, 2019

    6th World Congress and Expo on Applied Microbiology

    Rome, Italy
    October 23-24, 2019

    2nd Global Experts Meeting on Chronic Diseases

    Tokyo, Japan
    November 06-07, 2019 |

    15th Global Summit on Virology and Microbiology

    Yokohama | Japan
    November 14-15, 2019

    23rd World Congress on Biotechnology

    Amsterdam, Netherlands
    December 04-05, 2019

    Orthodontics and Prosthodontics

    Tokyo, Japan

    Vaccines and the Microbiome Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in